US FDA recommends less frequent liver testing with pravastatin

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 1997年 / 650卷 / 1期

关键词：

Liver Disease; Liver Function Testing; World Wide; Pravastatin; Reductase Inhibitor;

D O I：

10.2165/00128415-199706500-00003

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：2 / 2

相关论文

共 50 条

[1] US FDA recommends LC-HRMS for testing ranitidine products
Reactions Weekly, 2019, 1774 (1) : 6 - 6
[2] US FDA recommends transition to disposable duodenoscopes
Burki, Talha
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (06): : 509 - 509
[3] The US recommends hepatitis C testing
Marlene Cimons
Nature Medicine, 1997, 3 : 1060 - 1060
[4] The US recommends hepatitis C testing
Cimons, M
NATURE MEDICINE, 1997, 3 (10) : 1060 - 1060
[5] FDA panel recommends approval of first gene therapy in US
Dyer, Owen
BMJ-BRITISH MEDICAL JOURNAL, 2017, 358
[6] US agency recommends opportunistic HIV testing
Roehr, Bob
BRITISH MEDICAL JOURNAL, 2006, 333 (7570): : 669 - 669
[7] Less frequent drug testing required
不详
PIPELINE & GAS JOURNAL, 1997, 224 (02) : 8 - 8
[8] The Case for Less, Not More, US FDA Regulation
Vernon, John A.
Golec, Joseph H.
PHARMACOECONOMICS, 2011, 29 (08) : 637 - 640
[9] The Case for Less, Not More, US FDA Regulation
John A. Vernon
Joseph H. Golec
PharmacoEconomics, 2011, 29 : 637 - 640
[10] US Senate limits FDA testing
Kohl, M
JOURNAL OF REFRACTIVE SURGERY, 1997, 13 (07): : 612 - 612

← 1 2 3 4 5 →